U.S. markets closed

GSK plc (GSK)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
44.75+0.23 (+0.52%)
At close: 04:00PM EDT
44.55 -0.20 (-0.45%)
After hours: 07:25PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close44.52
Bid44.76 x 1200
Ask44.84 x 1100
Day's Range44.68 - 45.14
52 Week Range37.80 - 46.97
Avg. Volume5,187,831
Market Cap113.754B
Beta (5Y Monthly)0.29
PE Ratio (TTM)17.76
Earnings DateN/A
Forward Dividend & Yield1.99 (4.46%)
Ex-Dividend DateMay 19, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
-4% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for GSK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • GSK plc
    Analyst Report: GlaxoSmithKline PLCGlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory and infectious diseases, and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care products, and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne. The company has approximately 90,000 employees.
    Fair Value
    Economic Moat
    22 days agoArgus Research
View more